BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia

Presse/Médias: Commentaire d'expert

période	16 févr. 2016

titre	BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia
!!Media name / outlet	Cancer Therapy Advisor
Pays	États-Unis
la date	16/02/16
URL	www.cancertherapyadvisor.com/chronic-myeloid-leukemia-cml-bcrabl-tki-cardiovascular-risk/article/474331/
Personnes	Jonathan Douxfils